The U.S. Food and Drug Administration (FDA), a chief U.S. regulatory body, has aired concern over the safety of nano-silver, the name given to the experimental drug Nigeria's ministry of health annnounced it would be using to treat eight Ebola patients in Lagos.Erica Jefferson, a spokeswoman for the FDA, claimed they could not find or verify any information on the treatment, though they did not explicitly call it by name.
The U.S. Environmental Protection Agency classifies nano-silver, a known anti-bacterial used to fight mold and other bacteria, a pesticide. Makers of products that contain it must register and receive clearance.
The U.S. FDA says it has gotten complaints about the Ebola treatment claims. The Nigerian government claims the treatment was given by a Nigerian scientist in the diaspora, but did not give the doctor's name.